• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    3/26/24 1:45:27 PM ET
    $AHG
    $AKBA
    $APCX
    $BCAN
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AHG alert in real time by email

    Shares of Westport Fuel Systems Inc. (NASDAQ:WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss.

    Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

    Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Stoke Therapeutics, Inc. (NASDAQ:STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome.
    • C3is Inc. (NASDAQ:CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results.
    • OpGen, Inc. (NASDAQ:OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million.
    • Mesoblast Limited (NASDAQ:MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease.
    • Praxis Precision Medicines Inc (NASDAQ:PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR.
    • Nuvation Bio Inc (NYSE:NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy.
    • Check-Cap Ltd. (NASDAQ:CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI.
    • Viking Therapeutics Inc (NASDAQ:VKTX) shares climbed 23.3% to $85.29 after the company announced results from its Phase 1 multiple ascending dose clinical trial of an oral tablet formulation of VK2735.
    • Krispy Kreme, Inc. (NASDAQ:DNUT) gained 21.3% to $15.10 after the company and McDonald's expanded their partnership, with Krispy Kreme to provide donuts at McDonald's locations nationwide.
    • Journey Medical Corp (NASDAQ:DERM) gained 19.9% to $3.50.
    • Akso Health Group (NASDAQ:AHG) climbed 17.5% to $1.21.
    • 9F Inc – ADR (NASDAQ:JFU) gained 17% to $3.50.
    • Invivyd, Inc. (NASDAQ:IVVD) gained 17% to $3.78. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.
    • Sunnova Energy International Inc (NYSE:NOVA) shares gained 16.4% to $6.28 after the company announced that it will be the sole provider of solar and battery storage services in The Home Depot stores across the United States and its territories.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) climbed 16.3% to $0.18 after surging 24% on Monday. Greenwave Technology Solutions 13G filing showed Joseph Reda reported a 9.119% stake in the co as of March 22, 2024.
    • Reddit Inc (NYSE:RDDT) climbed 15.8% to $69.26 amid post-IPO volatility.
    • Canopy Growth Corp (NASDAQ:CGC) shares gained 15.6% to $7.17.
    • Qurate Retail Inc (NASDAQ:QRTEB) climbed 13.7% to $4.40.
    • Natural Grocers by Vitamin Cottage Inc (NYSE:NGVC) climbed 13.4% to $19.25.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares rose 9.8% to $0.2660 after dipping 10% on Monday.
    • Seagate Technology Holdings PLC (NASDAQ:STX) gained 9.2% to $96.33 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $73 to $115.
    • McCormick & Company Inc (NYSE:MKC) climbed 9% to $76.24 after the company reported better-than-expected first-quarter financial results.
    • IHS Holding Ltd (NYSE:IHS) climbed 7.6% to $3.74.
    • Tesla Inc (NASDAQ:TSLA) gained 5.8% to $182.65 amid reports suggest Italy has approached the company about electric truck production.

    Losers

    • Quhuo Limited (NASDAQ:QH) dipped 68.5% to $0.40.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) fell 51.8% to $0.48 after declining around 3% on Monday.
    • Cardlytics Inc (NASDAQ:CDLX) dipped 40.4% to $12.06 after the company announced a $150 million proposed convertible senior notes offering.
    • AppTech Payments Corp. (NASDAQ:APCX) fell 39.3% to $1.00 after the company priced its 2 million share offering at $1 per share.
    • Next.e.GO N.V. (NASDAQ:EGOX) shares tumbled 27.6% to $0.037 after jumping around 30% on Monday.
    • Professional Diversity Network Inc (NASDAQ:IPDN) fell 27.2% to $1.82.
    • Canoo Inc (NASDAQ:GOEV) shares fell 21.4% to $3.30.
    • GDS Holdings Limited (NASDAQ:GDS) fell 20.2% to $6.68 after the company reported fourth-quarter results, disclosed equity raise and new CEO for its international business.
    • Equillium Inc (NASDAQ:EQ) shares declined 20.1% to $1.95 following fourth-quarter results.
    • BYND Cannasoft Enterprises (NASDAQ:BCAN) shares fell 17.9% to $1.61.
    • Murano Global Investments Plc (NASDAQ:MRNO) shares declined 17.9% to $14.78.
    • Dada Nexus Limited (NASDAQ:DADA) shares dropped 17.8% to $2.08 after the company reported downbeat fourth-quarter results.
    • Etao International (NASDAQ:ETAO) shares fell 14.7% to $4.35.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) fell 14.4% to $1.24 after posting fourth-quarter results.
    • Akebia Therapeutics Inc (NASDAQ:AKBA) shares dipped 9.5% to $2.00.
    • Graphjet Technology (NASDAQ:GTI) fell 9.3% to $7.26.
    • Monte Rosa Therapeutics Inc (NASDAQ:GLUE) dipped 8.4% to $7.75.
    • Consol Energy Inc (NYSE:CEIX) declined 8.1% to $79.36.
    • RH (NYSE:RH) fell 4% to $276.00. Telsey Advisory Group analyst Joseph Feldman reiterated RH with a Market Perform and maintained a $285 price target.

     

    Now Read This: Ethereum Surpasses $3,600; dogwifhat Emerges As Top Gainer

    Get the next $AHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHG
    $AKBA
    $APCX
    $BCAN

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Equillium Inc.
    $EQ
    2/25/2026$5.00Buy
    Stifel
    Stoke Therapeutics Inc.
    $STOK
    2/24/2026$40.00Outperform
    Wolfe Research
    Praxis Precision Medicines Inc.
    $PRAX
    2/24/2026$500.00Outperform
    Wolfe Research
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Reddit Inc.
    $RDDT
    2/6/2026$245.00 → $250.00Buy
    B. Riley Securities
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Praxis Precision Medicines Inc.
    $PRAX
    2/2/2026$282.00Equal Weight
    Wells Fargo
    More analyst ratings

    $AHG
    $AKBA
    $APCX
    $BCAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Stifel initiated coverage on Equillium with a new price target

    Stifel initiated coverage of Equillium with a rating of Buy and set a new price target of $5.00

    2/25/26 7:52:10 AM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Stoke Therapeutics with a new price target

    Wolfe Research initiated coverage of Stoke Therapeutics with a rating of Outperform and set a new price target of $40.00

    2/24/26 7:56:29 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $AKBA
    $APCX
    $BCAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Taneja Vaibhav converted options into 6,538 shares and sold $899,077 worth of shares (2,264 units at $397.03), increasing direct ownership by 31% to 18,106 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    3/9/26 7:00:14 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Director Rooney David C. converted options into 1,532 shares, increasing direct ownership by 8% to 20,364 units (SEC Form 4)

    4 - Natural Grocers by Vitamin Cottage, Inc. (0001547459) (Issuer)

    3/6/26 5:01:19 PM ET
    $NGVC
    Food Chains
    Consumer Staples

    Director Cerkovnik Edward converted options into 1,532 shares, increasing direct ownership by 3% to 61,748 units (SEC Form 4)

    4 - Natural Grocers by Vitamin Cottage, Inc. (0001547459) (Issuer)

    3/6/26 5:00:50 PM ET
    $NGVC
    Food Chains
    Consumer Staples

    $AHG
    $AKBA
    $APCX
    $BCAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GDS Announces Results of Extraordinary General Meeting and of Additional Shareholders Meetings

    SHANGHAI, China, March 10, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ:GDS, HKEX: 9698)), a leading developer and operator of high-performance data centers in China, today announced that the adjourned extraordinary general meeting of shareholders of the Company (the "2026 EGM") was held on March 10, 2026. The Company also held adjourned meetings of each of the holders of the class A ordinary shares (the "Class A Shareholders Meeting"), the holders of the Series A preferred shares (the "Series A Preferred Shareholders Meeting"), the holders of the Series B preferred shares (the "Series B Preferred Shareholders Meeting) and the holders of th

    3/10/26 7:30:00 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    KRISPY KREME® is Bringing Guests 'All the Luck' this St. Patrick's Day with Fun Doughnuts, Sweeter Deals and a Chance to Win Free Doughnuts for a Year

    $12 Green O'riginal Glazed dozens return, plus guests who wear green March 16-17 can receive a free Green O'riginal Glazed® doughnut Lucky you! Krispy Kreme® is making St. Patrick's Day celebrations the luckiest with a new doughnut collection, the return of the Green O'riginal Glazed® doughnut, and offers so good, you'll think you've found a pot of gold. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260309637564/en/$12 Green O'riginal Glazed dozens return, plus guests who wear green March 16-17 can receive a free Green O'riginal Glazed® doughnut Available Tuesday, March 10 through St. Patrick's Day, March 17 at participating

    3/9/26 6:00:00 AM ET
    $DNUT
    Food Chains
    Consumer Staples

    Viking Therapeutics to Participate at Upcoming Investor Conferences

    SAN DIEGO, March 5, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at multiple upcoming investor conferences.  Details of the company's participation are as follows:Leerink Partners Global Healthcare Conference 2026Details: Viking management will participate in a fireside chat and in 1-on-1 meetingsConference Date: March 8-11, 2026Fireside Chat Timing: 10:40 – 11:10 a.m. Eastern

    3/5/26 4:03:00 PM ET
    $VKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $AKBA
    $APCX
    $BCAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $AHG
    $AKBA
    $APCX
    $BCAN
    SEC Filings

    View All

    SEC Form 6-K filed by Murano Global Investments PLC

    6-K - Murano Global Investments Plc (0001988776) (Filer)

    3/10/26 9:00:16 AM ET
    $MRNO
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 144 filed by Tesla Inc.

    144 - Tesla, Inc. (0001318605) (Subject)

    3/6/26 5:42:03 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 10-Q filed by Greenwave Technology Solutions Inc.

    10-Q - Greenwave Technology Solutions, Inc. (0001589149) (Filer)

    3/6/26 5:26:06 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    $AHG
    $AKBA
    $APCX
    $BCAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Butler John P. bought $86,588 worth of shares (69,270 units at $1.25), increasing direct ownership by 2% to 3,367,064 units (SEC Form 4)

    4 - Akebia Therapeutics, Inc. (0001517022) (Issuer)

    3/5/26 6:55:46 PM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $9,578 worth of shares (29,606 units at $0.32), increasing direct ownership by 0.91% to 3,300,000 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:57:43 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $AHG
    $AKBA
    $APCX
    $BCAN
    Leadership Updates

    Live Leadership Updates

    View All

    Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

    Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at Harvard Medical School and Brigham and Women's Hospital, Dr. Mina strengthens Invivyd's medical leadership Dr. Mina's research at Harvard focused on antibodies, vaccines, and infectious diseases with special expertise in COVID-19, measles, and other diseases, and will be a significant asset to Invivyd and the advancement of its pipelineWith more than 100 scientific publications and 10,000 citations, as well as hundreds of popular press interviews and op-eds, Dr. Mina is an expert in conducting research and conveying its meaning and impact to healthc

    3/5/26 7:01:00 AM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Natural Grocers® Opens Its Doors in Ruidoso, NM With a Grand Opening Celebration on March 18, 2026

    Customers will enjoy unbeatable savings, exciting giveaways, sweepstakes, delicious samples and moreLAKEWOOD, Colo., March 3, 2026 /PRNewswire/ -- Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S., is pleased to announce the opening of its newest store in Ruidoso, NM, on Wednesday, March 18, 2026. Conveniently located at 25992 US-70 #1, this will be Natural Grocers' seventh store in New Mexico. Community members are invited to join the celebration with giveaways, fabulous savings, free samples, a prize wheel, live local radio and more.

    3/3/26 7:15:00 AM ET
    $NGVC
    Food Chains
    Consumer Staples

    Natural Grocers® Celebrates Wyoming's 307 Day with a Special Gift and Savings March 7-9, 2026

    LAKEWOOD, Colo., March 2, 2026 /PRNewswire/ -- Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S., invites customers to celebrate Wyoming's 307 Day, March 7–9 at its two Wyoming stores. Customers can mark the occasion with a free Natural Grocers reusable tote bag and a $5-off coupon for in-store purchases, available to all {N}power® members. NATURAL GROCERS – WYOMINGHeadquartered in Colorado, Natural Grocers expanded into Wyoming in July 2010 with the opening of its first store in Cheyenne, followed by a store in Casper in May 2011. Th

    3/2/26 7:29:00 AM ET
    $NGVC
    Food Chains
    Consumer Staples

    $AHG
    $AKBA
    $APCX
    $BCAN
    Financials

    Live finance-specific insights

    View All

    Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

    Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.7 million after raising over $200 million from financing transactions in 2H 2025Announced initiation of DECLARATION Phase 3 pivotal clinical trial of vaccine-alternative antibody VYD2311 to prevent COVID, with top-line data expected mid-2026; Fast Track designation for VYD2311 granted by FDA in December 2025DECLARATION trial on track with full enrollment achievedDECLARATION trial Independent Data Monitoring Committee (IDMC) prespecified review of unblinded VYD2311 safety data resulted in IDMC re

    3/5/26 7:03:00 AM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results

    Cardlytics, Inc. (NASDAQ:CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025. "In 2025, we took several steps to reset our business and improve our financial health," said Amit Gupta, CEO of Cardlytics. "Going forward, we remain well positioned to execute our mandate and deliver for our partners and advertisers, even as we navigate a decrease in MQUs following the conclusion of our Bank of America campaigns in January. We are moving forward with sharper focus and discipline to control our own destiny by prioritizing our initiatives that build on our core fundamental strengths." "It has been reinvigorating to rejoin the Cardlytics team," s

    3/4/26 4:02:00 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    GDS to Report Fourth Quarter and Full Year 2025 Financial Results Before the Open of the U.S. Market on March 17, 2026

    SHANGHAI, China, March 03, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ:GDS, HKEX: 9698)), a leading developer and operator of high-performance data centers in China, today announced that it will report its fourth quarter and full year 2025 unaudited financial results after the close of the Hong Kong market and before the open of the U.S. market on March 17, 2026. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Tuesday, March 17, 2026 (8:00 PM Hong Kong Time on the same day). Participants should complete online registration using the link provided below at least 15 minutes before the schedule

    3/3/26 6:00:00 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    $AHG
    $AKBA
    $APCX
    $BCAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Invivyd Inc.

    SC 13D/A - Invivyd, Inc. (0001832038) (Subject)

    12/12/24 4:39:09 PM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials